Unified Business No.

25147136

Industry

Tobacco Manufacturing (1,186)

Listing

Emerging stock (TPEx) (359) 6610

Founded

2010-07-16

Paid-in capital

NT$ 2,055,793,950

Phone

02-26571788

Website

https://www.twibiotech.com/

Exporter

Yes — registered with the Trade Administration

Annual revenue band

NT$100–500M estimated

Ownership

Group subsidiary / corporate-held · Hsin Chen Tou Tzu Co., Ltd.

Representative tenure

In office since 2020-09 (6 yrs); last handover 2020-09 (same surname)

Growth & profitability

Revenue 2026-09 YoY —, year-to-date —

Patents 2

• 2026 Crystalline form of 3-hydroxy-5-pregnan-20-one derivative, pharmaceutical composition comprising the same, preparation method and use thereof
• 2024 Topical formulation comprising tofacitinib

Similar companies 10

• LYTONE ENTERPRISE, INC. Emerging stock (TPEx) NT$0.5–1B
  Shared: General R&D services
• PROTRADE APPLIED MATERIALS CORP. Emerging stock (TPEx) ≥ NT$5B
  Shared: General R&D services
• FORTUNE ADVANCED TECHNOLOGY CO., LTD. Emerging stock (TPEx) NT$100–500M
  Shared: General R&D services
• TMY TECHNOLOGY INC. Emerging stock (TPEx) NT$0.5–1B estimated
  Shared: General R&D services
• aiPlex Corporation Listed (TWSE) NT$20–100M
  Shared: General R&D services
• GENETICS GENERATION ADVANCEMENT CORP. (GGA CORP.) Listed (TPEx) NT$0.5–1B
  Shared: General R&D services
• MediVisionTech Co., Ltd. · Tainan City < NT$20M estimated
  Shared: General R&D services
• GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS CORPORATION Emerging stock (TPEx) < NT$20M
  Shared: General R&D services
• APOLLO ENERGY TECHNOLOGY CO., LTD. · New Taipei City NT$20–100M estimated
  Shared: General R&D services
• ANALOG INTEGRATIONS CORP. Listed (TPEx) NT$1–5B
  Shared: General R&D services

Open in advanced filters →